Latest News
Press release
12th May 2008Accentus Medical receives ISO 13485-2003 Accreditation
Accentus Medical is pleased to announce that, following a succesful audit by their notified body - LRQA, the company has been awarded the prestigious ISO 13485-2003 accreditation.Martin Pickford, Managing Director of Accentus Medical stated : "Following our successful audit by the US Food and Drug Administration, eighteen months ago, this approval means that the company is now licensed as a fully compliant medical device manufacturer in the two major markets of the world. It is a recognition of the professionalism and dedication of our employees and will be of considerable assistance in our efforts to establish Accentus Medical as the leader in its field of the development and application of bioactive surface coatings to medical devices."
Click here for a copy of the ISO-13485-2003 certificate.
ENDS
Press Release
29th January 2008Accentus Medical Appoints Exclusive Agent in France and Switzerland
Accentus Medical, the leading UK supplier of specialist coatings to manufacturers of joint replacement implants, has today appointed Thomas Salomon as its exclusive agent for the company's plasma spray coating business in the important orthopaedic markets of France and Switzerland.
Martin Pickford, Managing Director of Accentus Medical, stated:
"There is a very strong tradition for local manufacture of medical devices in these geographic markets, and as a consequence there are many potential customers for our clinically proven coatings. Thomas Salomon has been directly involved in supplying this market segment for many years. He will therefore be able to help build our business by utilising his in-depth knowledge of both the technical requirements and the customer base in France and Switzerland. We are very excited about our prospects for growth in these significant territories."
This appointment represents the latest stage in the international expansion of Accentus Medical outside of its UK base, and follows recent approval of the company by the US Food and Drug Administration as a coating and medical device manufacturer for the lucrative USA market.
Contact details for Thomas Salomon are as follows.
Tel +33 (0) 6 81 36 03 28
Email thomas.salomon@accentus-medical.co.uk
Press Release
25th January 2008Latest News on Agluna™ Technology
Accentus Medical has today announced that the number of patients who have received patient-specific tumour mega-prostheses modified with Agluna™ biocidal surface enhancement has now surpassed 30.
These patient-specific prostheses are manufactured and distributed by Stanmore Implants Worldwide Ltd (SIW), with the Agluna™ surface enhancement supplied by SIW under licence from Accentus Medical. The devices have mainly been implanted at the Royal National Orthopaedic Hospital in London and at the Royal Orthopaedic Hospital in Birmingham, although recently patients in mainland Europe have also received Agluna™ modified implants.
The first patient-specific prosthesis utilising the Agluna™ surface modification was implanted in March 2006, and it is hoped to increase the patient
cohort to 100 by the end of 2008.
Click here to download a summary of the types of procedures carried out to date using mega-prostheses treated with Agluna™ technology
ENDS
For further information please contact Kirsten Robinson in the press office on 0845 226 0803.
Press Release
14th November 2007New technology developed by Accentus Medical presented at ISOLS
On 13 September, at the International Symposium on Limb Salvage (ISOL) in Hamburg Germany, Dr Paul Unwin, CEO and General Manager of Stanmore Implants Worldwide Ltd (SIW), presented to a group of leading European orthopaedic surgeons, a new orthopaedic surface modification technology developed by Accentus Medical.
Utilising a wet chemistry technique, the process developed by the Accentus Medical research and development team led by Managing Director, Dr Martin Pickford, produces a silver biocide surface modification to titanium or titanium alloy implants.
During laboratory testing the concentration of silver within the surface has been shown to be effective in eliminating many strains of bacteria which are commonly found in orthopaedic patients suffering from post-operative infections.
The
new surface technique known as AglunaTM has been used to date on 18
patients receiving patient-specific custom made tumor implants manufactured by SIW, with
encouraging results.
Stanmore
Implants approached Accentus Medical in 2002, to create a new surface for their
patient-specific mega-prostheses that would help reduce problems of infection. In March 2006, the first Stanmore Implant
patient received the AglunaTM modified implant.
Click here to download presentation
ENDS
For further information please contact Kirsten Robinson in the press office on 0845 226 0803.
Press Release
13th July 2007Accentus
Medical and Stanmore Implants present new technology to British Orthopaedic
Oncology Society
New orthopaedic technology developed by Accentus Medical and used by Stanmore Implants Worldwide Ltd on patient-specific custom and massive orthopaedic endoprostheses was presented on 6th July to surgeons attending the British Orthopaedic Oncology Society Annual Scientific Meeting in London.
The process developed by the Accentus Medical research and development team, produces a silver biocide surface modification to titanium or titanium alloy implants. The concentration of silver within the surface has been shown to be effective in eliminating bacteria.
Stanmore Implants approached Accentus Medical in 2002, to create a new surface for their patient-specific mega-prostheses that would help reduce problems of infection. The new surface technique known as AglunaTM has been used in seventeen patients so far with very encouraging results. Following the presentation, plans are now in preparation with a view to expanding this patient-specifc study to all Orthopaedic Oncology centres in the UK.
Click here to download presentation
ENDS
For further information please contact Kirsten Robinson in the press office on 0845 226 0803.
- Designed by Sitemakers
-
Sitemakers are web specialists. If you are interested in having a website built by us, visit our website today!
www.sitemakers.com